Stockreport

Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips [Seeking Alpha]

Sana Biotechnology, Inc.  (SANA) 
PDF SC451's planned 2026 IND is the primary catalyst going forward. In my view, this is their make-or-break catalyst this year. A favorable Phase 1 trial could rapidly re [Read more]